CClinicalTrials.gg
CompletedNCT04121689Updated Oct 10, 2019

Time Course of Postprandial Protein Metabolism

An interventional study of Milk Protein Concentrate in Muscle Protein Synthesis and Protein Metabolism, sponsored by University of Illinois at Urbana-Champaign. Completed at 1 site in United States. Open to male participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-10.

Sponsored by University of Illinois at Urbana-Champaign · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 4 years 11 months after the study started (first participant enrolled Oct 2014, registered Sep 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
7
Allocation
Not applicable
Ages
18 Years to 35 Years
Sex
Male
01

Study summary

The anabolic action of 'fast' whey protein on the regulation of postprandial muscle protein synthesis has been established to be short-lived in healthy young adults. Our aim was assess the time course of anabolic signaling events and stimulation of muscle protein synthesis rates (MPS) after ingestion of a food source that represents a more typical meal-induced pattern of aminoacidemia, namely milk protein concentrate, in healthy young males.

02

Conditions studied

  • Muscle Protein Synthesis
  • Protein Metabolism

Keywords

  • Protein
  • Amino Acids
  • Anabolic Signaling
  • Muscle Mass
03

In context

Lead sponsor

University of Illinois at Urbana-Champaign is the lead sponsor of 188 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Males
  • Aged between 18-35 years
  • Healthy, recreationally active
  • BMI \< 30 kg/m2

Exclusion criteria

Exclusion criteria

  • Smoking
  • Allergies to milk proteins
  • Vegetarians
  • Diagnosed GI tract diseases
  • Female
  • Arthritic conditions
  • A history of neuromuscular problems
  • Previous participation in amino acid tracer studies
  • Predisposition to hypertrophic scarring or keloid formation
  • Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
7 participants (actual)

Study arms

  • Experimental
    Milk Protein Concentrate

    Seven young men (age: 22±1 y) will undergo repeated blood and biopsy sampling during primed continuous L-\[ring-2H5\]phenylalanine and L-\[1-13C\]leucine tracer infusions, and ingested 38 g of L-\[1-13C\]phenylalanine- and L-\[1-13C\]leucine-labeled milk protein concentrate

    Dietary Supplement: Milk Protein Concentrate

Interventions

  • Dietary supplementMilk Protein Concentrate

    The macronutrient composition and energy of the milk protein beverage provided to participants is 38 g protein (3.46 g leucine), 4.17 g carbohydrate, and 1.4 g fat. The milk protein met all chemical and bacteriologic specifications for human consumption. The L-\[1-13C\]phenylalanine and L-\[1-13C\]leucine enrichments in the milk protein concentrate averaged 38.3 and 10.8 mole percent excess (MPE), respectively.

06

What researchers measure

Primary outcomes

  1. Fractional synthesis rates of myofibrillar protein

    Myofibrillar protein synthesis rates will be assessed during the postabsorptive period for 3 hours, and every 1-2 hours during the 5 hours after protein ingestion. This will allow us assess the timecourse of muscle protein synthesis after eating.

    Time frame: 8 hours

Secondary outcomes

  1. Phosphorylation of muscle anabolic signaling

    Phosphorylation of anabolic signaling pathways (mTORC1, AKT, and P70S6K) involved in the stimulation of myofibrillar protein synthesis rates will be assessed during the postabsorptive period for 3 hours, and every 1-2 hours during the 5 hours after protein ingestion.

    Time frame: 8 hours

  2. Exogenous rate of phenylalanine appearance

    Dietary derived phenylalanine availability will be measured during the 5 h postprandial phase to determine its relationship with the fractional synthesis rates of myofibrillar protein and phosphorylation of muscle anabolic signaling

    Time frame: 5 hours

07

Study locations

1 site
  • Freer Hall
    Urbana, Illinois 61801, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 10, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04121689
Lead sponsor
University of Illinois at Urbana-Champaign
Responsible party
Sponsor
First posted
Oct 10, 2019
Start date
Oct 1, 2014
Primary completion
Nov 1, 2014
Completion
Aug 26, 2019
Last update
Oct 10, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion